Tokyo Tape
Sign in
← Taiyo Holdings

Quarterly report · Q3

4626.TEDINET S100SPJ2
Period2023-04-01 → 2023-12-31
Filed2024-02-02
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥78.0bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥97.3bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥76.8bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥14.3bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥14.3bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥13.8bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥15.5bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥13.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥13.8bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥13.9bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥10.2bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥11.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥10.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥10.2bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥10.3bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥204.6bnat 2023-12-31Cons.Assets
Total assets¥187.3bnat 2023-03-31Cons.Assets
Total assets¥190.1bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥104.1bnat 2023-12-31Cons.Liabilities
Total liabilities¥94.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥100.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥92.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥91.3bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥49.8bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥47.1bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥182.542023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥70.882023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥203.712022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥184.092022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥50.672022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio49.1%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio49.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio48.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥2.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥244m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31¥47m
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue2023-04-01 → 2023-12-31¥53.3bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue external2023-04-01 → 2023-12-31¥53.3bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥0
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentsegment profit2023-04-01 → 2023-12-31¥12.4bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue2023-04-01 → 2023-12-31¥22.1bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue external2023-04-01 → 2023-12-31¥22.1bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentsegment profit2023-04-01 → 2023-12-31¥2.9bn
—segment totalrevenue2023-04-01 → 2023-12-31¥75.4bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥75.4bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥0
—segment totalsegment profit2023-04-01 → 2023-12-31¥15.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥78.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥78.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥244m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥15.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥2.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥217m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥1m
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue2022-04-01 → 2022-12-31¥55.3bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue external2022-04-01 → 2022-12-31¥55.3bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥0
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentsegment profit2022-04-01 → 2022-12-31¥14.2bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue2022-04-01 → 2022-12-31¥18.9bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue external2022-04-01 → 2022-12-31¥18.9bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.4bn
—segment totalrevenue2022-04-01 → 2022-12-31¥74.2bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥74.2bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥0
—segment totalsegment profit2022-04-01 → 2022-12-31¥15.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥77.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥76.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥217m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥15.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 345
ItemContextValueUnit
Liabilities and net assetsPrior1YearInstant187263000000JPY
Liabilities and net assetsCurrentQuarterInstant204565000000JPY
Net salesPrior1YTDDuration76772000000JPY
Net salesCurrentYTDDuration78040000000JPY
Cost of salesPrior1YTDDuration42170000000JPY
Cost of salesCurrentYTDDuration41552000000JPY
Gross profitPrior1YTDDuration34602000000JPY
Gross profitCurrentYTDDuration36487000000JPY
Selling general and administrative expensesPrior1YTDDuration20332000000JPY
Selling general and administrative expensesCurrentYTDDuration22230000000JPY
Operating incomePrior1YTDDuration14269000000JPY
Operating incomeCurrentYTDDuration14256000000JPY
Interest income noiPrior1YTDDuration68000000JPY
Interest income noiCurrentYTDDuration162000000JPY
Dividends income noiPrior1YTDDuration29000000JPY
Dividends income noiCurrentYTDDuration20000000JPY
Subsidy income noiPrior1YTDDuration64000000JPY
Subsidy income noiCurrentYTDDuration29000000JPY
Other noiPrior1YTDDuration214000000JPY
Other noiCurrentYTDDuration135000000JPY
Non operating incomePrior1YTDDuration377000000JPY
Non operating incomeCurrentYTDDuration347000000JPY
Interest expenses noePrior1YTDDuration345000000JPY
Interest expenses noeCurrentYTDDuration478000000JPY
Foreign exchange losses noePrior1YTDDuration262000000JPY
Foreign exchange losses noeCurrentYTDDuration84000000JPY
Other noePrior1YTDDuration127000000JPY
Other noeCurrentYTDDuration270000000JPY
Non operating expensesPrior1YTDDuration735000000JPY
Non operating expensesCurrentYTDDuration833000000JPY
Ordinary incomePrior1YTDDuration13910000000JPY
Ordinary incomeCurrentYTDDuration13771000000JPY
Income before income taxesPrior1YTDDuration13910000000JPY
Income before income taxesCurrentYTDDuration13771000000JPY
Income taxes currentPrior1YTDDuration3378000000JPY
Income taxes currentCurrentYTDDuration3081000000JPY
Income taxes deferredPrior1YTDDuration213000000JPY
Income taxes deferredCurrentYTDDuration493000000JPY
Income taxesPrior1YTDDuration3591000000JPY
Income taxesCurrentYTDDuration3575000000JPY
Profit lossPrior1YTDDuration10319000000JPY
Profit lossCurrentYTDDuration10196000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-0JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-0JPY
Profit loss attributable to owners of parentPrior1YTDDuration10320000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration10196000000JPY
Profit lossPrior1YTDDuration10319000000JPY
Profit lossCurrentYTDDuration10196000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration103000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration340000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass